Medications for Anxiety and Depression
For patients with both anxiety and depression, SSRIs are the first-line treatment option, with sertraline being the most recommended due to its well-established safety profile and efficacy for both conditions. 1
First-Line Medications
SSRIs (Selective Serotonin Reuptake Inhibitors)
Sertraline:
Escitalopram:
- Dose: 10-20 mg daily
- Well-tolerated alternative to sertraline 1
Fluoxetine:
Common SSRI Side Effects
- Gastrointestinal: nausea, diarrhea
- Neurological: headache, insomnia
- Sexual dysfunction
- Risk of serotonin syndrome when combined with other serotonergic agents 4
- Increased risk of suicidal thinking in patients under 24 years 4
Second-Line Medications
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
Venlafaxine:
Duloxetine:
Other Options
Mirtazapine:
Buspirone:
- Starting dose: 15 mg daily
- Target dose: 20-30 mg daily
- Non-SSRI, non-controlled medication for anxiety
- Advantages: less sexual dysfunction, lower risk of withdrawal symptoms 1
Medications to Avoid or Use with Caution
Benzodiazepines (e.g., alprazolam):
- While effective for anxiety 5, they should be used cautiously due to:
- Risk of dependence
- Sedation and fall risk
- Not effective for depression
- Not recommended for long-term use
Tricyclic Antidepressants:
- Significant cardiovascular side effects including hypertension, hypotension, and arrhythmias 2
- Should be avoided, especially in patients with cardiovascular disease
Monoamine Oxidase Inhibitors:
- Significant cardiovascular side effects 2
- Multiple drug and food interactions
- Should be avoided in most patients
Treatment Approach
Start with an SSRI (preferably sertraline) at a low dose and gradually increase
- Allow 8-12 weeks to evaluate full response 1
- Monitor for side effects and adjust dose as needed
If partial response or intolerable side effects:
- Switch to another SSRI or consider an SNRI
- Approximately 38% of patients do not achieve treatment response during 6-12 weeks of treatment with a single antidepressant 2
For treatment-resistant cases:
- Consider combination therapy or augmentation strategies
- Consider referral to a psychiatrist
Non-pharmacological approaches:
- Cognitive Behavioral Therapy (CBT) is highly effective and should be considered alongside medication 1
- Regular exercise and stress management techniques can help reduce symptoms
Special Considerations
Suicidality monitoring: Patients, especially those under 24 years, should be monitored for emergence of suicidal thoughts, particularly during the first few weeks of treatment 4
Discontinuation: Medication should be continued for at least 12-24 months after achieving remission and should be tapered gradually to avoid withdrawal symptoms 1
Elderly patients: Start with lower doses and monitor closely for side effects 1
Comorbid conditions: Adjust medication choice based on comorbidities (e.g., pain, insomnia, cardiovascular disease)
By following this evidence-based approach, most patients with anxiety and depression can achieve significant symptom improvement and better quality of life.